4.6 Article

Clinical characteristics and treatment outcome of depression in patients with and without a history of emotional and physical abuse

期刊

JOURNAL OF PSYCHIATRIC RESEARCH
卷 44, 期 5, 页码 302-309

出版社

PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.jpsychires.2009.09.008

关键词

Life events; Emotional abuse; Physical abuse; Sexual abuse; Depression; Mood; Spectrum

资金

  1. NIMH [MH65376, MH30915]
  2. Fondazione IDEA, Italy
  3. Forest Research Institute
  4. Pittsburgh Foundation
  5. AstraZeneca
  6. Merck Sharp Dohme Italia
  7. Organon Italia
  8. Bayer
  9. Pfizer Italia
  10. Lundbeck Italia
  11. Bristol-Meyers Squibb
  12. GlaxoSmithKline

向作者/读者索取更多资源

Clinical features and treatment outcome were compared in depressed outpatients with and without a history of emotional and physical abuse (EPA), including childhood maltreatment. Patients were initially randomized to IPT or SSRI and then augmented with the second treatment if they did not remit with monotherapy. Assessments included the SCID-I, the SCID-II for DSM-IV diagnoses, the HRSD, the QIDS and the Mood Spectrum Self-Report (MOODS-SR). Seventy-eight (25%) patients reported a history of EPA; 60 (76.9%) were women. Patients with a history of EPA did not differ from those without on HRSD scores at baseline, but showed an earlier age at onset of depression and a longer duration of illness. The two groups differed on several mood spectrum factors, namely: 'depressive mood' (15.6 +/- 4.9 vs. 13.5 +/- 5.4; p < 0.004), 'psychomotor retardation' (11.7 +/- 4.5 vs. 9.6 +/- 4.7; p < 0.001), 'drug and illness-related depression' (1.3 +/- 1.3 vs. 0.6 +/- 1.0; p < 0.0001), and 'neurovegetative symptoms' (8.3 +/- 2.6 vs. 6.9 +/- 2.9; p < 0.0001). Patients with EPA had also a significantly longer time to remission (89 vs. 67 days, log-rank test, p = 0.035). The need for augmentation treatment was significantly more frequent among patients with EPA than in those without. The present study suggests that patients with a history of EPA show a subtype of depression characterized by poor treatment response and more severe neurovegetative and psychomotor symptoms. (C) 2009 Elsevier Ltd. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据